Virtus LifeSci Biotech Clinical Trials ETF Rating → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free BBC Stock Alerts $27.43 -0.05 (-0.18%) (As of 05/9/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Virtus LifeSci Biotech Clinical Trials ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBC Aggregate RatingModerate Buy2.84Holdings in BBC have an aggregate rating of Moderate Buy based on 345 analyst ratings issued in the past year covering 49 companies (65.1% of the portfolio).BBC Aggregate Price Target$43.4058.25% UpsideHigh Prediction$62.48Average Prediction$43.40Low Prediction$27.29Holdings in BBC have an aggregate price target of $43.40 and a range of $27.29 to $62.48 covering 49 companies (65.1% of the portfolio).BBC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy21 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Clinical Trials ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBC Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.18%VKTXViking Therapeutics$80.20+0.4%5 of 5 stars3.00$112.25 40.0%102.74%ALPNAlpine Immune Sciences$64.82+0.2%2 of 5 stars2.27$50.33 -22.3%11Positive News2.64%CGEMCullinan Oncology$27.17-2.0%3 of 5 stars3.00$31.00 14.1%7Insider Selling2.57%RNAAvidity Biosciences$27.10+4.0%1 of 5 stars3.00$36.86 36.0%7Upcoming EarningsInsider SellingNews CoveragePositive News2.30%VERAVera Therapeutics$42.33-5.8%0 of 5 stars3.00$32.29 -23.7%8News CoverageGap Down1.93%SANASana Biotechnology$7.50-21.0%2 of 5 stars2.75$11.67 55.6%4Analyst ForecastNews CoverageGap Down1.83%SYRESpyre Therapeutics$35.19+6.6%0 of 5 stars3.00$41.00 16.5%8News Coverage1.75%APGEApogee Therapeutics$52.92+3.2%3 of 5 stars3.00$71.83 35.7%8Analyst ForecastPositive News1.75%DYNDyne Therapeutics$25.95+1.0%3 of 5 stars3.13$37.75 45.5%8Analyst Revision1.68%IBRXImmunityBio$8.06+1.8%0 of 5 stars2.00$6.00 -25.6%1Gap Up1.49%MRUSMerus$45.12-4.2%1 of 5 stars3.00$56.33 24.9%11Earnings ReportAnalyst ForecastNews Coverage1.48%GERNGeron$3.88+1.8%4 of 5 stars2.80$6.10 57.2%51.45%LQDALiquidia$12.48-0.2%2 of 5 stars2.60$21.00 68.3%5Positive News1.42%SMMTSummit Therapeutics$4.78-3.6%2 of 5 stars3.00$7.50 56.9%2Analyst Forecast1.38%CYTKCytokinetics$64.02-1.9%4 of 5 stars2.87$81.60 27.5%15Earnings ReportAnalyst ForecastInsider SellingNews CoverageGap Up1.37%KROSKeros Therapeutics$57.60-1.1%3 of 5 stars3.00$86.00 49.3%7Earnings ReportAnalyst ForecastNews Coverage1.36%KURAKura Oncology$20.77+1.1%3 of 5 stars2.88$28.28 36.1%81.34%MGNXMacroGenics$14.67+0.1%4 of 5 stars2.89$18.00 22.7%9Upcoming EarningsNews CoverageHigh Trading Volume1.30%IOVAIovance Biotherapeutics$13.45+0.4%5 of 5 stars3.00$24.64 83.2%10News Coverage1.29%BCYCBicycle Therapeutics$23.58-0.2%1 of 5 stars2.86$46.86 98.7%71.24%MLYSMineralys Therapeutics$14.27-2.6%3 of 5 stars3.00$33.50 134.8%3News Coverage1.22%FDMT4D Molecular Therapeutics$25.64-2.6%2 of 5 stars3.00$44.22 72.5%10Gap Down1.19%RVMDRevolution Medicines$37.45-2.2%4 of 5 stars3.10$41.60 11.1%10Earnings ReportAnalyst ForecastGap Up1.17%NRIXNurix Therapeutics$13.95-0.2%2 of 5 stars2.83$21.33 52.9%61.17%IGMSIGM Biosciences$10.12+8.4%4 of 5 stars2.50$17.89 76.8%8Analyst ForecastGap Down1.14%KYMRKymera Therapeutics$38.61+0.3%0 of 5 stars2.50$41.10 6.4%121.12%COGTCogent Biosciences$7.92+4.2%2 of 5 stars2.71$13.67 72.6%7Earnings ReportAnalyst ForecastAnalyst Revision1.10%KRYSKrystal Biotech$158.74+0.7%4 of 5 stars3.00$171.00 7.7%9Earnings ReportAnalyst RevisionNews Coverage1.09%ANABAnaptysBio$26.23+1.9%3 of 5 stars2.80$46.22 76.2%10News Coverage1.03%ALXOALX Oncology$16.95+2.0%1 of 5 stars2.83$18.83 11.1%6Insider SellingNews Coverage1.03%CRNXCrinetics Pharmaceuticals$49.42-2.9%3 of 5 stars2.92$57.58 16.5%12Analyst ForecastNews Coverage1.02%SLNOSoleno Therapeutics$47.64+3.0%4 of 5 stars3.00$55.60 16.7%5Upcoming EarningsNews CoverageGap Down1.00%INBXInhibrx$34.69+0.7%2 of 5 stars2.00$27.00 -22.2%2Upcoming EarningsNews Coverage0.99%DAWNDay One Biopharmaceuticals$16.38-0.2%3 of 5 stars2.86$37.67 130.0%7Analyst ForecastAnalyst Revision0.99%PTGXProtagonist Therapeutics$28.27+4.3%2 of 5 stars3.00$38.00 34.4%4Analyst ForecastAnalyst RevisionNews Coverage0.96%IDYAIDEAYA Biosciences$40.64-1.9%3 of 5 stars3.00$47.50 16.9%12Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.92%LYELLyell Immunopharma$2.68+7.2%1 of 5 stars2.50$5.50 105.2%2Analyst Forecast0.91%ARDXArdelyx$8.06-5.0%5 of 5 stars3.11$12.81 59.0%9Insider Selling0.90%XNCRXencor$23.54-0.5%4 of 5 stars2.89$36.00 52.9%9Upcoming EarningsNews Coverage0.89%PGENPrecigen$1.29-3.0%3 of 5 stars2.33$10.00 675.2%3Upcoming EarningsNews Coverage0.88%SNDXSyndax Pharmaceuticals$21.97-1.8%4 of 5 stars2.91$34.42 56.7%11Earnings ReportAnalyst ForecastNews Coverage0.88%CMPSCOMPASS Pathways$8.54+0.5%1 of 5 stars3.00$47.40 455.0%50.88%IMTXImmatics$10.64+0.1%0 of 5 stars3.0010.88%ITOSiTeos Therapeutics$12.19-0.1%1 of 5 stars3.00$30.33 148.8%3News Coverage0.87%CLDXCelldex Therapeutics$41.06-0.4%1 of 5 stars2.80$66.00 60.7%5Analyst ForecastAnalyst RevisionNews Coverage0.86%ALLOAllogene Therapeutics$2.86+3.6%2 of 5 stars2.71$13.50 372.0%7Upcoming Earnings0.85%BHVNBiohaven$41.36+1.4%3 of 5 stars3.00$52.13 26.0%80.84%PCVXVaxcyte$65.57-1.8%1 of 5 stars3.00$78.50 19.7%4Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap Down0.83%PHATPhathom Pharmaceuticals$10.09-0.1%2 of 5 stars2.80$22.00 118.0%5Earnings ReportAnalyst ForecastGap Down This page (NYSEARCA:BBC) was last updated on 5/10/2024 by MarketBeat.com Staff From Our PartnersYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
